2nd Quarter - Report

INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA

Firm
Client
Income
—
Expenses
$132,560
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; Physician payment cuts; Medicaid and Medicare Reform, including Medicare Prescription Drug Coverage; Average Sales Price; and Competitive Acquisition Program

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P., Public Policy & Government Relations
KIMBERLY ANN MILLER New HIV Medicine Assocation Policy Officer
R MICHAEL OCHS Government Relations Associate
JASON SCULL Program Officer for Clinical Affairs
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH)

Medical/Disease Research/Clinical Labs MED

Medical liability; Antimicrobial resistance research; infectious diseases product research and development

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P., Public Policy & Government Relations
JULIE HANTMAN Senior Program Officer for Public Health
PADMA NATARAJAN Program Officer for Science and Research
R MICHAEL OCHS Government Relations Associate

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); U.S. Agency for International Development (USAID); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Infectious Diseases; drug and vaccine research and development; antimicrobial resistance; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P., Public Policy & Government Relations
JULIE HANTMAN Senior Program Officer for Public Health
KIMBERLY ANN MILLER New HIV Medicine Association Policy Officer
PADMA NATARAJAN Program Officer for Science and Research
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources & Services Administration, Food & Drug Administration and global programs for various infectious diseases related issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P., Public Policy & Government Relations
JULIE HANTMAN Senior Program Officer for Public Health
KIMBERLY ANN MILLER New HIV Medical Association Policy Officer
PADMA NATARAJAN Program Officer for Science and Research
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medical Association

Contacted: Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Affiliated organisations

OrganisationLocation
HIV MEDICINE ASSOCIATION Arlington, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.